Who benefits most from adjuvant interferon treatment for melanoma?

  • Helen Gogas
  • , Huseyin Abali
  • , Paolo A. Ascierto
  • , Lev Demidov
  • , Hubert Pehamberger
  • , Caroline Robert
  • , Jacob Schachter
  • , Alexander M.M. Eggermont
  • , Axel Hauschild
  • , Enrique Espinosa

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Who benefits most from adjuvant interferon treatment for melanoma?'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science